Wellmedr vs MedVi: Pricing, Meds, Shipping, Support
Comparing Wellmedr vs MedVi quickly: Wellmedr emphasizes lower starting pricing and multiple GLP-1 options, while MedVi highlights a simple online process, a $179 first-month promo and 24/7 certified medical support. Early verdict: choose Wellmedr if you want lower starting costs and tirzepatide availability; choose MedVi if you prefer a streamlined, no-clinic workflow and round-the-clock clinical support.
Start WellMedr plans from $89/mo
Head-to-head: the most distinctive differences
This comparison focuses on the three most distinctive supported differences between Wellmedr vs MedVi: starting price and pricing model, medication options and compounding/regulatory notes, and service features such as shipping speed, review timing, and clinical support.
1. Starting price and pricing model
Wellmedr advertises GLP-1 plans starting at $89/month and marketing materials reference plans for semaglutide starting at $49/month and tirzepatide starting at $89/month. Wellmedr promotes lifetime locked-in pricing and no dose-based price increases. MedVi promotes a winter promotional first-month price of $179 with fast, free shipping; captured evidence notes ongoing rates rise after the promotion and standalone months can be substantially higher, with a three-month plan option and a $99 membership referenced in some captured content. The sources preserve that MedVi’s initial promo is lower than its ongoing refill price.
See MedVi $179 first-month promo
2. Medication options and compounding notes
Wellmedr offers both tirzepatide and semaglutide plans and explicitly states it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies, with the required notice that compounded medications are not evaluated by the FDA for safety or efficacy. MedVi provides clinically dosed compounded semaglutide only, and its captured materials state compounded GLP-1s are produced in regulated facilities but are not FDA-approved or evaluated for safety, effectiveness or quality. Both providers include regulatory notes that compounded medications are not FDA-approved.
3. Service features: review timing, shipping, and clinical support
Wellmedr advertises same-day review plus free overnight shipping and on-time refills guaranteed. MedVi emphasizes a simple online intake with no clinic visits required and 24/7 support from certified medical professionals, plus fast, free shipping for the promotional month. MedVi also notes a clinician review after checkout and that clinicians retain prescription decisions.
| Criteria | Wellmedr | MedVi |
|---|---|---|
| Starting price | $89/mo for GLP-1 plans (semaglutide from $49/mo listed on landing materials) | $179 first-month promo; ongoing refill price is higher per captured FAQ |
| Medications offered | Tirzepatide and semaglutide options | Compounded semaglutide only |
| Compounded status | Compounded GLP-1s from licensed U.S. pharmacies; not FDA-evaluated | Compounded semaglutide produced in regulated facilities; not FDA-approved |
| Clinical support | Same-day review advertised; clinician approval required | No clinic visits; 24/7 certified medical support and clinician review after checkout |
| Shipping and refills | Free overnight shipping and on-time refills guaranteed per landing content | Fast, free shipping for promo month; partnerships with certified pharmacies |
Pricing nuance and guarantees
Wellmedr’s materials highlight lifetime locked-in pricing, no dose-based price increases, and promotional messaging about lock-in savings in captured landing content. MedVi’s captured content emphasizes a promotional first-month price of $179 with free shipping, and the materials caution that the ongoing refill price is higher and that a three-month plan or membership options exist. Both sources include clinician review and eligibility screening language; MedVi specifically notes OpenLoop Health clinicians make prescribing decisions.
Check WellMedr pricing and plans
Safety, outcomes, and limitations
Both providers’ captured content preserves the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr’s content includes a required safety notice listing potential risks such as thyroid C-cell tumors and medullary thyroid carcinoma and advises seeking immediate care for symptoms. MedVi materials urge users to discuss risks with providers and note that results vary and that medication prescriptions are at the discretion of medical providers.
Conclusion: choose based on price, medication choice, or support model
Wellmedr vs MedVi differ primarily on starting price structure, available medications, and service model. Wellmedr emphasizes lower advertised starts, lifetime locked-in pricing, tirzepatide availability, and same-day review with overnight shipping. MedVi emphasizes a streamlined online process with no clinic visits, a $179 first-month promo with fast free shipping, and 24/7 certified medical support, while noting ongoing prices can be higher.
Start MedVi with $179 first-month promo
Choose Wellmedr if you prioritize lower advertised starting costs, the availability of tirzepatide as well as semaglutide, lifetime locked-in pricing and advertised same-day review plus free overnight shipping. Choose MedVi if you prioritize a simple online intake with no clinic visits and 24/7 certified medical support and want the promotional first-month pricing for semaglutide. All treatment plans require medical evaluation and clinician approval; compounded medications are not FDA-approved and may carry specific risks.